COMMUNIQUÉS West-GlobeNewswire

Health Coalition Issues Open Letter to Health Minister to Stop Transfer of Lab Testing by Quest/Lifelabs to U.S.
15/06/2026
TORONTO, June 15, 2026 (GLOBE NEWSWIRE) -- Hon. Sylvia Jones Minister of Health 5 th Floor 777 Bay St., Toronto, ON M7A 2J3 By email: sylvia.jones@ontario.ca Dear Minister Jones, We are writing to ask that you stop [...]
Grant of Warrants
15/06/2026
June 15, 2026 Announcement no. 13 Grant of Warrants Copenhagen, Denmark, June 15, 2026, (GLOBE NEWSWIRE) – The Board of Directors of BioPorto A/S (“BioPorto” or the “Company”) (CPH:BIOPOR) has today decided to issue a [...]
Adaptive Biotechnologies Corporation Announces Proposed Convertible Senior Notes Offering
15/06/2026
Proceeds expected to be deployed to repay the OrbiMed Purchase Agreement to enhance financial flexibility Additional proceeds used to pay for the capped call with a premium of at least 75% and to repurchase up to $25 [...]
Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology
15/06/2026
Nyxoah’s Genio® Wins Prix Galien UK 2026 Award for Best Medical Technology Mont-Saint-Guibert, Belgium – June 15, 2026, 10:05 pm CET / 04:05 pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company [...]
The Ensign Group, Inc. Announces Increased Stock Repurchase Authorization
15/06/2026
SAN JUAN CAPISTRANO, Calif., June 15, 2026 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG) (“Ensign” or the “Company”), the parent company of the Ensign TM group of companies, which invest in and provide [...]
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities
15/06/2026
ZUG, Switzerland, June 15, 2026 (GLOBE NEWSWIRE) -- The attached notification relates to the purchase of ordinary shares by a member of the Company’s Executive Committee. Attachment notification-of-managers-transaction- [...]
Adaptive Biotechnologies Announces Plan to Separate Its MRD and Immune Medicine Businesses
15/06/2026
MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune Medicine has built a differentiated discovery platform powered by proprietary immune data and AI SEATTLE, June 15, 2026 (GLOBE [...]
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares
15/06/2026
REYKJAVIK, Iceland, June 15, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar [...]
Rhythm Pharmaceuticals Announces Multiple New Data Presentations from MC4R Agonists in Acquired Hypothalamic Obesity (HO), Bardet-Biedl Syndrome (BBS) and Prader-Willi Syndrome (PWS) at ENDO 2026
15/06/2026
-- Setmelanotide therapy achieved robust, sustained and clinically significant weight loss in patients with acquired HO at 2.5 years -- - - Bivamelagon therapy achieved progressive reductions in BMI and hunger measures [...]
J-Star Holding Announces Receipt of Nasdaq Delisting Determination; Class A Ordinary Shares Expected to Continue Trading Pending Nasdaq Hearings Panel Review
15/06/2026
TAICHUNG CITY, Taiwan, June 15, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), today announced that on June 12, 2026, it received a Staff Delisting Determination Letter [...]
La Thérapie Genio® de Nyxoah Remporte le Prix Galien UK 2026 de la Meilleure Technologie Médicale
15/06/2026
La Thérapie Genio® de Nyxoah Remporte le Prix Galien UK 2026 de la Meilleure Technologie Médicale Mont-Saint-Guibert, Belgique – 15 juin 2026, 22h05 CET / 16h05 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« [...]
Alvotech Announces Proposed $125 Million Public Offering and Concurrent Private Placement of Ordinary Shares
15/06/2026
REYKJAVIK, ICELAND (June 15, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients [...]
Confo Therapeutics Announces Encouraging Preclinical Data for Post-bariatric Hypoglycemia Candidate CFTX-2034 at ENDO 2026
15/06/2026
Data support the potential of CFTX-2034 as a first-in-class treatment for PBH and advancement toward Phase 1 clinical development Ghent, Belgium – June 15, 2026 – Confo Therapeutics , a clinical-stage biotechnology [...]
Sanofi: Information concerning the total number of voting rights and shares – May 2026
15/06/2026
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l’ [...]
Boston Business Journal names Interra Health to 2026 Best Places to Work List
15/06/2026
BOSTON, June 15, 2026 (GLOBE NEWSWIRE) -- The Boston Business Journal has named Interra Health to its 2026 Best Places to Work — the BBJ’s exclusive ranking of the Massachusetts companies that have built outstanding [...]
Curaechoice Partners with Capitol Imaging Services to Deliver Greater Access to No-Cost Diagnostic Imaging for Program Members
15/06/2026
Partnership Enhances Members’ Access to Comprehensive Imaging Services including MRI, CT, PET/CT, and Women's Health Imaging Across Six Southern States Birmingham, ALABAMA, June 15, 2026 (GLOBE NEWSWIRE) -- Curaechoice [...]
GENFIT: June 15, 2026 Combined Shareholders Meeting Results
15/06/2026
All resolutions recommended by the Board of Directors approved (quorum: 32.13 %) Lille (France); Cambridge, ( Massachusetts, United States); Zurich (Switzerland); June 15, 2026 - GENFIT (Euronext: GNFT) , , a [...]
Ethyreal Bio Presents First Preclinical Data on ETHY-001 at ENDO 2026, Demonstrating Complete Blockade of Autoantibody Activation of TSHR and Differentiated Activity in TED
15/06/2026
– ETHY-001 produced complete blockade of autoantibody-mediated TSHR activation across all patient serum samples tested, demonstrating breadth and consistency of effect – – In TED patient-derived orbital fibroblasts, [...]
GENFIT : Résultats de l’Assemblée Générale Mixte du 15 juin 2026
15/06/2026
L’ensemble des projets de résolutions recommandés par le Conseil d’Administration a été approuvé (quorum : 32,13 %) Lille (France), Cambridge (Massachusetts, États-Unis), Zurich (Suisse), le 15 juin 2026 – GENFIT ( [...]

Pages